Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lanreotide (BIM 23014) diTFA, a somatostatin analogue, exhibits antineoplastic activity and may be utilized in carcinoid syndrome research [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Lanreotide (BIM 23014) diTFA, a somatostatin analogue, exhibits antineoplastic activity and may be utilized in carcinoid syndrome research [1] [2]. |
In vitro | Lanreotide (BIM 23014) at 100 nM concentration, increased apoptosis when combined with radiation over a period of 0 to 48 hours [1]. |
In vivo | Lanreotide administered subcutaneously at dosages ranging from 2.5 to 10 mg/kg daily for five consecutive days leads to the inhibition of tumor growth [1]. |
Alias | BIM 23014 diTFA |
Molecular Weight | 1324.37 |
Formula | C58H71F6N11O14S2 |
Cas No. | 1024499-83-9 |
Storage | keep away from moisture | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.